Company
Grace Therapeutics, Inc. (GRCE)
Standardized SEC financial data for Grace Therapeutics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001444192 · NASDAQ · Pharmaceutical Preparations.
Gross margin
100.0%
Operating margin
-16.7%
Net margin
-9.6%
Revenue growth (YoY)
50920.4%
Return on equity
-14.4%
Free cash flow
-$14.9M
Current ratio
11.77×
EPS (diluted)
$-0.79
Ratios for fiscal year 2022, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | — | $196K | $100.0M | — | — | — |
| Cost of revenue |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $14.2M | $60.7M | $30.3M | $27.9M | $23.0M | $22.1M |
| Accounts receivable |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$23.0M | -$14.3M | -$17.2M | -$15.9M | -$12.3M | -$14.9M |
| Investing cash flow |
Get GRCE data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/GRCE/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/GRCE/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"